TY - CHAP M1 - Book, Section TI - Nonalcoholic Fatty Liver Disease A1 - Friedman, Lawrence S. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. PY - 2023 T2 - Current Medical Diagnosis & Treatment 2023 AB - Key Clinical Updates in Nonalcoholic Fatty Liver DiseaseNoninvasive approaches to the assessment of fibrosis are now preferred, with liver biopsy reserved when results of noninvasive testing are inconclusive. The FIB-4 score is often used particularly to exclude advanced fibrosis because of its simplicity. It is based on age, platelet count, and serum AST and ALT levels.Younossi ZM et al. Am J Gastroenterol. [PMID: 33284184] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193152448 ER -